Experts in the News: Steven Austad, James Cuvillier, and Ai-Ling Lin new research on how rapamycin improves memory and blood flow to the brain in older rats in Aging Cell
On November 6, 2019, Aging Cell published research by AFAR experts Steven N. Austad, PhD, James Cuvillier, MD, and Ai-Ling Lin, PhD, connecting rapamycin to improved memory and blood flow to the brain in older rats, which holds implications for aging research and offers an avenue to prevent Alzheimer’s dementia.
Dr. Austad is AFAR’s Scientific Director. He is also a distinguished professor and Chair of the Department of Biology at the University of Alabama at Birmingham, as well as Co Principle-Investigator of the Nathan Shock Centers of Excellence in the Basic Biology of Aging Coordinating Center.
Dr. Cuvillier is a 2013 Medical Student Training in Aging Research (MSTAR) recipient, as well as a Resident Physician at the University of Texas Health Center of San Antonio.
Dr. Lin is a 2012 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, as well as an Associate Professor in the Department of Pharmacology and Nutritional Sciences at the Sanders-Brown Center on Aging at the University of Kentucky.
Read the research, “mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging,” here.
Read a press release summary of the research in Science Daily, “Rapamycin prevents age-related brain vascular deterioration in rats,” here.